SOFOSBUVIR

SOFOSBUVIR was reported 19622 times

SOFOSBUVIR is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HEPATIC HYDROTHORAX 25 0.3165
1 HEPATITIS C RNA POSITIVE 47 0.2749
2 GENOTYPE DRUG RESISTANCE TEST POSITIVE 223 0.2169
3 AMAUROSIS FUGAX 211 0.1959
4 TRANSCATHETER ARTERIAL CHEMOEMBOLISATION 6 0.1714
5 REMISSION NOT ACHIEVED 98 0.1576
6 HEPATITIS C 1736 0.1436
7 HEPATITIS C RNA INCREASED 48 0.1404
8 HEPATIC CANCER RECURRENT 38 0.1338
9 HEPATITIS C RNA 6 0.1304
10 HEPATOCELLULAR CARCINOMA 911 0.1197
11 OESOPHAGEAL VARICEAL LIGATION 7 0.1077
12 CRYOGLOBULINAEMIA 74 0.1035
13 PORTOPULMONARY HYPERTENSION 7 0.0787
14 HEPATITIS C VIRUS TEST POSITIVE 41 0.0697
15 CHRONIC HEPATITIS C 27 0.0684
16 THERAPEUTIC EMBOLISATION 20 0.0641
17 GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE 33 0.0630
18 BLEEDING VARICOSE VEIN 34 0.0628
19 COMPLICATIONS OF TRANSPLANTED LUNG 19 0.0619
20 GENITAL HERPES SIMPLEX 11 0.0519
21 OESOPHAGEAL VARICES HAEMORRHAGE 108 0.0497
22 HYDROCHOLECYSTIS 9 0.0486
23 HEPATITIS B REACTIVATION 137 0.0431
24 URINARY TRACT DISORDER 188 0.0417
25 HEPATECTOMY 13 0.0415
26 HEPATORENAL SYNDROME 66 0.0391
27 HEPATIC ENCEPHALOPATHY 364 0.0390
28 GASTRIC VARICES HAEMORRHAGE 12 0.0366
29 LIVER TRANSPLANT 133 0.0365
30 VIRAL TEST POSITIVE 13 0.0358
31 ABDOMINAL CAVITY DRAINAGE 14 0.0332
32 VIRAL LOAD INCREASED 120 0.0309
33 CHOROIDITIS 11 0.0294
34 HYPERBILIRUBINAEMIA 296 0.0285
35 EXPOSURE VIA DIRECT CONTACT 27 0.0284
36 HAEMORRHAGIC STROKE 221 0.0283
37 ACUTE ON CHRONIC LIVER FAILURE 6 0.0278
38 DIABETIC HYPERGLYCAEMIC COMA 9 0.0276
39 PORTAL HYPERTENSIVE GASTROPATHY 15 0.0266
40 VIRAL MUTATION IDENTIFIED 96 0.0260
41 INCARCERATED HERNIA 8 0.0258
42 VIROLOGIC FAILURE 131 0.0243
43 PORPHYRIA NON-ACUTE 10 0.0230
44 PORTAL VEIN THROMBOSIS 73 0.0226
45 ASCITES 646 0.0220
46 GENE MUTATION IDENTIFICATION TEST POSITIVE 9 0.0214
47 HEPATIC CIRRHOSIS 386 0.0205
48 AMMONIA ABNORMAL 8 0.0199
49 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 48 0.0194
50 OCULAR DISCOMFORT 218 0.0194
51 VARICES OESOPHAGEAL 55 0.0182
52 HEPATIC FAILURE 547 0.0181
53 SINUS NODE DYSFUNCTION 33 0.0180
54 EXPOSURE VIA PARTNER 9 0.0179
55 GENERALISED OEDEMA 213 0.0172
56 HEPATIC HAEMATOMA 8 0.0169
57 LIVER TRANSPLANT REJECTION 30 0.0167
58 COMPLICATIONS OF TRANSPLANTED LIVER 6 0.0167
59 EXPOSURE VIA BODY FLUID 13 0.0165
60 RENAL TUBULAR DYSFUNCTION 9 0.0159
61 GASTRIC VARICES 7 0.0149
62 BLOOD BILIRUBIN ABNORMAL 19 0.0148
63 COMA HEPATIC 11 0.0148
64 GASTROINTESTINAL ANGIODYSPLASIA 6 0.0146
65 HEPATITIS E 23 0.0146
66 MESENTERIC VEIN THROMBOSIS 14 0.0140
67 THOUGHT BLOCKING 8 0.0136
68 HEPATITIS B DNA INCREASED 9 0.0134
69 MACROGLOSSIA 7 0.0127
70 HEAD DISCOMFORT 220 0.0124
71 THERAPY RESPONDER 6 0.0122
72 PORTAL HYPERTENSION 37 0.0120
73 HAEMATEMESIS 299 0.0118
74 SINOATRIAL BLOCK 7 0.0117
75 PACKED RED BLOOD CELL TRANSFUSION 15 0.0113
76 PREGNANCY OF PARTNER 8 0.0113
77 HEPATOBILIARY DISEASE 7 0.0112
78 ALTERED STATE OF CONSCIOUSNESS 242 0.0112
79 SOFT TISSUE INFECTION 20 0.0109
80 NODULAR REGENERATIVE HYPERPLASIA 7 0.0109
81 C-REACTIVE PROTEIN DECREASED 7 0.0107
82 HEPATIC CANCER METASTATIC 9 0.0105
83 GENITAL HERPES 16 0.0105
84 PHOTOSENSITIVITY REACTION 167 0.0101
85 TREATMENT FAILURE 837 0.0101
86 EXPOSURE VIA FATHER 13 0.0100
87 ALPHA 1 FOETOPROTEIN INCREASED 7 0.0098
88 INFECTION REACTIVATION 11 0.0096
89 GRANULOMA ANNULARE 7 0.0095
90 DRUG LEVEL CHANGED 6 0.0095
91 ASTERIXIS 10 0.0094
92 PHOTOPHOBIA 176 0.0093
93 HEPATIC FIBROSIS 32 0.0093
94 BLOOD BILIRUBIN INCREASED 249 0.0092
95 HEPATIC NEOPLASM 30 0.0092
96 PNEUMOCOCCAL SEPSIS 6 0.0091
97 JAUNDICE 241 0.0089
98 PRESYNCOPE 216 0.0089
99 PERITONITIS BACTERIAL 88 0.0087
100 AMMONIA INCREASED 43 0.0084
101 BLOOD BILIRUBIN UNCONJUGATED INCREASED 6 0.0083
102 BILIARY COLIC 23 0.0079
103 FIBROSIS 24 0.0078
104 ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC 6 0.0078
105 DIPLOPIA 198 0.0076
106 HYPERSENSITIVITY VASCULITIS 20 0.0076
107 ACUTE LEUKAEMIA 12 0.0074
108 MITOCHONDRIAL TOXICITY 6 0.0073
109 HEPATIC MASS 14 0.0073
110 ALANINE AMINOTRANSFERASE DECREASED 5 0.0069
111 JC VIRUS INFECTION 11 0.0069
112 STREPTOCOCCAL SEPSIS 8 0.0067
113 INTESTINAL INFARCTION 6 0.0066
114 HAEMOLYTIC ANAEMIA 58 0.0065
115 RETINAL EXUDATES 6 0.0064
116 INTERVERTEBRAL DISCITIS 12 0.0064
117 KLEBSIELLA BACTERAEMIA 6 0.0063
118 ANAEMIA 1190 0.0062
119 ANAL CANCER 6 0.0062
120 HEPATIC PAIN 26 0.0061
121 CHOLANGIOCARCINOMA 9 0.0060
122 SUNBURN 45 0.0060
123 LIP EXFOLIATION 8 0.0060
124 HAEMATURIA 204 0.0060
125 HEPATIC CANCER 143 0.0059
126 PRODUCT DIFFICULT TO SWALLOW 6 0.0059
127 HEPATIC LESION 25 0.0058
128 VIRAEMIA 8 0.0058
129 CARDIO-RESPIRATORY ARREST 240 0.0057
130 RENAL TUBULAR DISORDER 16 0.0057
131 ACUTE PSYCHOSIS 14 0.0057
132 ERYSIPELAS 28 0.0056
133 LIP BLISTER 15 0.0055
134 BLINDNESS 223 0.0055
135 DYSENTERY 10 0.0054
136 KLEBSIELLA SEPSIS 6 0.0053
137 OESOPHAGEAL HAEMORRHAGE 7 0.0053
138 INFECTIOUS PLEURAL EFFUSION 8 0.0053
139 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 11 0.0052
140 BILE DUCT STENOSIS 6 0.0050
141 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 6 0.0050
142 HEPATITIS B 30 0.0050
143 COMA 237 0.0050
144 TRANSFUSION 52 0.0050
145 GLOMERULONEPHRITIS 12 0.0049
146 TINNITUS 225 0.0049
147 ENCEPHALOPATHY 118 0.0048
148 HYPERAMMONAEMIA 24 0.0048
149 HIV INFECTION 14 0.0046
150 CALCULUS URINARY 7 0.0045
151 EYE OEDEMA 11 0.0045
152 TRANSPLANT DYSFUNCTION 8 0.0045
153 IRRITABILITY 265 0.0044
154 LEFT VENTRICULAR FAILURE 15 0.0044
155 SINUS BRADYCARDIA 42 0.0043
156 ANAL PRURITUS 9 0.0043
157 LUNG ADENOCARCINOMA 13 0.0043
158 PATHOGEN RESISTANCE 39 0.0043
159 INFLUENZA LIKE ILLNESS 352 0.0043
160 ALCOHOL ABUSE 11 0.0041
161 CHILLS 472 0.0040
162 EYE PAIN 227 0.0040
163 TACHYARRHYTHMIA 10 0.0040
164 INSOMNIA 1065 0.0040
165 TRANSPLANT REJECTION 32 0.0040
166 HAEMOGLOBIN DECREASED 402 0.0039
167 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 5 0.0039
168 VIOLENCE-RELATED SYMPTOM 6 0.0039
169 BLOOD HIV RNA INCREASED 7 0.0039
170 B-CELL LYMPHOMA 13 0.0038
171 ESCHERICHIA SEPSIS 11 0.0038
172 ANAEMIA MACROCYTIC 8 0.0037
173 GLYCOSYLATED HAEMOGLOBIN DECREASED 6 0.0037
174 PULMONARY ARTERIAL HYPERTENSION 54 0.0037
175 OCULAR ICTERUS 16 0.0037
176 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 8 0.0036
177 MYOCARDIAL NECROSIS MARKER INCREASED 6 0.0036
178 ENTEROBACTER INFECTION 6 0.0036
179 AFFECTIVE DISORDER 28 0.0036
180 PNEUMONIA STAPHYLOCOCCAL 7 0.0035
181 IMMUNE THROMBOCYTOPENIC PURPURA 10 0.0035
182 GLOMERULAR FILTRATION RATE DECREASED 42 0.0034
183 CEREBRAL HAEMATOMA 11 0.0033
184 PNEUMONIA KLEBSIELLA 6 0.0033
185 CHOLANGITIS 20 0.0032
186 LUPUS NEPHRITIS 6 0.0032
187 HAEMOLYSIS 24 0.0031
188 RENAL COLIC 7 0.0031
189 LIVER ABSCESS 10 0.0031
190 HYPERPYREXIA 13 0.0031
191 RED BLOOD CELL COUNT DECREASED 87 0.0030
192 SEPSIS 337 0.0030
193 AUTOIMMUNE HEPATITIS 21 0.0030
194 ACUTE CORONARY SYNDROME 25 0.0030
195 DRUG INTERACTION 476 0.0030
196 STAPHYLOCOCCAL BACTERAEMIA 13 0.0030
197 FATIGUE 2317 0.0030
198 HOMICIDAL IDEATION 12 0.0030
199 HERPES VIRUS INFECTION 17 0.0029
200 MULTI-ORGAN FAILURE 51 0.0029
201 SYNCOPE 294 0.0029
202 DUODENITIS 9 0.0029
203 BLADDER NEOPLASM 5 0.0029
204 HYPERURICAEMIA 12 0.0029
205 DRUG RESISTANCE 75 0.0029
206 TACHYCARDIA 259 0.0029
207 CHOLECYSTITIS INFECTIVE 8 0.0029
208 MYALGIA 489 0.0029
209 RENAL IMPAIRMENT 233 0.0028
210 HYPERPHAGIA 11 0.0028
211 INTRACRANIAL ANEURYSM 11 0.0027
212 LISTLESS 9 0.0027
213 SUPRAVENTRICULAR TACHYCARDIA 26 0.0027
214 NO THERAPEUTIC RESPONSE 33 0.0027
215 ACCIDENTAL DEATH 5 0.0027
216 METABOLIC ENCEPHALOPATHY 8 0.0027
217 HEPATITIS CHOLESTATIC 16 0.0027
218 EMBOLISM 22 0.0026
219 HEADACHE 1646 0.0026
220 UPPER GASTROINTESTINAL HAEMORRHAGE 44 0.0026
221 VIITH NERVE PARALYSIS 9 0.0026
222 DECREASED APPETITE 601 0.0026
223 ARTERIAL THROMBOSIS 5 0.0026
224 FACIAL PARALYSIS 22 0.0026
225 ACUTE KIDNEY INJURY 393 0.0026
226 APLASIA 5 0.0026
227 DEPRESSIVE SYMPTOM 9 0.0026
228 ESCHERICHIA BACTERAEMIA 6 0.0025
229 ENDOCARDITIS 13 0.0025
230 CACHEXIA 13 0.0025
231 CREATININE RENAL CLEARANCE DECREASED 10 0.0025
232 DIFFUSE LARGE B-CELL LYMPHOMA 19 0.0025
233 HEPATITIS ACUTE 16 0.0025
234 LIVER DISORDER 109 0.0025
235 SHOCK HAEMORRHAGIC 20 0.0025
236 HAEMATOTOXICITY 23 0.0024
237 PERSECUTORY DELUSION 6 0.0024
238 ACCIDENTAL OVERDOSE 88 0.0024
239 GASTROINTESTINAL TUBE INSERTION 6 0.0024
240 CONGESTIVE CARDIOMYOPATHY 10 0.0024
241 LYMPHOMA 37 0.0024
242 MOOD SWINGS 76 0.0024
243 ALANINE AMINOTRANSFERASE ABNORMAL 5 0.0024
244 MOOD ALTERED 64 0.0023
245 ANGINA UNSTABLE 15 0.0023
246 APHAGIA 11 0.0023
247 BLOOD ALBUMIN DECREASED 18 0.0023
248 ACUTE HEPATIC FAILURE 31 0.0023
249 DEPRESSION 512 0.0022
250 LIPASE INCREASED 17 0.0022
251 IRIDOCYCLITIS 7 0.0022
252 ENERGY INCREASED 13 0.0022
253 BILE DUCT STONE 7 0.0022
254 BRADYCARDIA 115 0.0022
255 RETINOPATHY 8 0.0021
256 ANAL HAEMORRHAGE 6 0.0021
257 BILIRUBIN CONJUGATED INCREASED 5 0.0021
258 VITAMIN B12 DECREASED 6 0.0021
259 ASTHENIA 781 0.0021
260 CLOSTRIDIAL INFECTION 7 0.0021
261 OPTIC ISCHAEMIC NEUROPATHY 8 0.0021
262 UROSEPSIS 19 0.0021
263 ABDOMINAL PAIN 478 0.0021
264 HYPERKALAEMIA 72 0.0021
265 MELAENA 45 0.0020
266 HEPATIC FUNCTION ABNORMAL 76 0.0020
267 SEPTIC SHOCK 88 0.0020
268 ATRIAL FLUTTER 16 0.0020
269 VISION BLURRED 275 0.0020
270 DERMATITIS EXFOLIATIVE 10 0.0020
271 FACIAL PARESIS 7 0.0020
272 HYPERTENSIVE CRISIS 22 0.0020
273 INTERNATIONAL NORMALISED RATIO DECREASED 8 0.0020
274 PSYCHOTIC DISORDER 58 0.0020
275 PANCREATITIS ACUTE 44 0.0020
276 TRANSAMINASES INCREASED 43 0.0019
277 PANCYTOPENIA 105 0.0019
278 ALCOHOLISM 8 0.0019
279 HAEMOGLOBIN ABNORMAL 12 0.0019
280 CHROMATURIA 42 0.0019
281 MENTAL IMPAIRMENT 45 0.0019
282 PRURITUS 712 0.0019
283 AUTOIMMUNE THYROIDITIS 7 0.0018
284 HAEMORRHOIDAL HAEMORRHAGE 9 0.0018
285 LEUKOPENIA 92 0.0018
286 SKIN DISORDER 61 0.0018
287 LACTIC ACIDOSIS 59 0.0018
288 CYTOMEGALOVIRUS INFECTION REACTIVATION 8 0.0018
289 DERMATITIS BULLOUS 13 0.0018
290 RENAL FAILURE 238 0.0018
291 CLOSTRIDIUM DIFFICILE COLITIS 19 0.0018
292 DRUG-INDUCED LIVER INJURY 56 0.0018
293 BK VIRUS INFECTION 6 0.0018
294 BLOOD CREATININE INCREASED 116 0.0018
295 DRUG DOSE OMISSION 293 0.0018
296 AFFECT LABILITY 17 0.0018
297 NAUSEA 1398 0.0018
298 GINGIVAL BLEEDING 24 0.0018
299 CEREBRAL ATROPHY 7 0.0018
300 NEPHROTIC SYNDROME 12 0.0017
301 ABDOMINAL PAIN UPPER 360 0.0017
302 IMMUNE SYSTEM DISORDER 23 0.0017
303 BLOOD CREATININE ABNORMAL 6 0.0017
304 THROMBOCYTOPENIA 194 0.0017
305 BLOOD URIC ACID INCREASED 10 0.0017
306 MULTIPLE ORGAN DYSFUNCTION SYNDROME 49 0.0017
307 HYPERTRANSAMINASAEMIA 12 0.0017
308 FORMICATION 12 0.0017
309 TROPONIN INCREASED 13 0.0017
310 YELLOW SKIN 8 0.0017
311 PYREXIA 586 0.0017
312 AORTIC DISSECTION 7 0.0017
313 DISTURBANCE IN ATTENTION 91 0.0017
314 CHRONIC LYMPHOCYTIC LEUKAEMIA 8 0.0017
315 FRUSTRATION 6 0.0017
316 HYPOALBUMINAEMIA 13 0.0017
317 CHEILITIS 9 0.0017
318 BACTERIAL INFECTION 31 0.0017
319 NORMAL NEWBORN 9 0.0017
320 LIP OEDEMA 7 0.0017
321 GASTROINTESTINAL HAEMORRHAGE 138 0.0016
322 CHOLELITHIASIS 54 0.0016
323 ASTHMATIC CRISIS 6 0.0016
324 PLATELET COUNT DECREASED 174 0.0016
325 COLITIS ISCHAEMIC 11 0.0016
326 THIRST 29 0.0016
327 BLOOD PRESSURE INCREASED 248 0.0016
328 STAPHYLOCOCCAL SEPSIS 8 0.0016
329 MATERNAL EXPOSURE BEFORE PREGNANCY 11 0.0016
330 SUDDEN DEATH 17 0.0016
331 NEPHROPATHY TOXIC 18 0.0016
332 PAROSMIA 12 0.0016
333 POLYURIA 13 0.0016
334 OFF LABEL USE 1389 0.0016
335 HYPERAESTHESIA 13 0.0016
336 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 13 0.0016
337 GASTROENTERITIS 23 0.0016
338 CONJUNCTIVAL HAEMORRHAGE 6 0.0016
339 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 6 0.0016
340 HEPATITIS 40 0.0016
341 THERAPEUTIC PRODUCT INEFFECTIVE 6 0.0016
342 VASCULITIS 18 0.0015
343 LUNG INFECTION 24 0.0015
344 HYPERGLYCAEMIA 56 0.0015
345 PETECHIAE 16 0.0015
346 EAR DISORDER 7 0.0015
347 BLOOD COUNT ABNORMAL 23 0.0015
348 MENTAL DISORDER 66 0.0015
349 ALANINE AMINOTRANSFERASE INCREASED 93 0.0015
350 HAEMATOCRIT DECREASED 30 0.0015
351 LOCALISED OEDEMA 7 0.0015
352 FLUID OVERLOAD 22 0.0015
353 CHOLESTASIS 29 0.0015
354 APPETITE DISORDER 10 0.0015
355 CEREBRAL HAEMORRHAGE 54 0.0015
356 ERYTHEMA MULTIFORME 14 0.0015
357 BLOOD DISORDER 12 0.0015
358 MENTAL STATUS CHANGES 41 0.0015
359 WHITE BLOOD CELL COUNT DECREASED 160 0.0015
360 DRUG LEVEL DECREASED 15 0.0015
361 SARCOIDOSIS 7 0.0015
362 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 14 0.0015
363 DRUG INEFFECTIVE 1931 0.0015
364 ARTHRITIS BACTERIAL 6 0.0015
365 COUGH 409 0.0015
366 TEMPERATURE INTOLERANCE 15 0.0015
367 GASTRIC ULCER HAEMORRHAGE 8 0.0014
368 NASAL DRYNESS 9 0.0014
369 DIZZINESS 716 0.0014
370 SOMNOLENCE 289 0.0014
371 VOMITING 674 0.0014
372 PRURITUS GENERALISED 31 0.0014
373 BACTERAEMIA 17 0.0014
374 SKIN ULCER 37 0.0014
375 HAEMODIALYSIS 12 0.0014
376 PHOTOPSIA 9 0.0014
377 HYPERVOLAEMIA 7 0.0014
378 CHOLECYSTITIS ACUTE 8 0.0014
379 MYOCARDIAL ISCHAEMIA 16 0.0014
380 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 7 0.0014
381 PULMONARY TUBERCULOSIS 6 0.0014
382 DYSPNOEA 789 0.0014
383 CARDIAC FLUTTER 9 0.0014
384 TOXIC SKIN ERUPTION 14 0.0014
385 FULL BLOOD COUNT DECREASED 28 0.0014
386 CHAPPED LIPS 6 0.0014
387 SUBARACHNOID HAEMORRHAGE 14 0.0014
388 ASPARTATE AMINOTRANSFERASE INCREASED 73 0.0014
389 HYPOVOLAEMIA 8 0.0014
390 FEELING OF BODY TEMPERATURE CHANGE 8 0.0014
391 CANDIDA INFECTION 23 0.0014
392 CEREBRAL ISCHAEMIA 7 0.0014
393 HYPERCHLORHYDRIA 8 0.0014
394 ARTHRALGIA 565 0.0014
395 VARICOSE VEIN 7 0.0014
396 BLOOD TEST ABNORMAL 19 0.0014
397 RASH GENERALISED 35 0.0014
398 FAILURE TO THRIVE 7 0.0013
399 UNEVALUABLE EVENT 102 0.0013
400 POOR QUALITY SLEEP 29 0.0013
401 ATRIOVENTRICULAR BLOCK COMPLETE 9 0.0013
402 APLASTIC ANAEMIA 7 0.0013
403 MANIA 22 0.0013
404 RASH 580 0.0013
405 ARRHYTHMIA 62 0.0013
406 APATHY 19 0.0013
407 ANGER 44 0.0013
408 EXTRASYSTOLES 9 0.0013
409 RESTLESSNESS 47 0.0013
410 SPLENOMEGALY 15 0.0013
411 DISSEMINATED INTRAVASCULAR COAGULATION 18 0.0013
412 HAND FRACTURE 9 0.0013
413 PYELONEPHRITIS 11 0.0013
414 EMOTIONAL DISORDER 39 0.0013
415 GASTRIC ULCER 24 0.0013
416 ANGINA PECTORIS 36 0.0013
417 MALAISE 550 0.0013
418 HYPOVOLAEMIC SHOCK 6 0.0013
419 VENTRICULAR EXTRASYSTOLES 13 0.0013
420 KIDNEY TRANSPLANT REJECTION 6 0.0012
421 TONGUE DISORDER 9 0.0012
422 STENT PLACEMENT 10 0.0012
423 HERPES SIMPLEX 8 0.0012
424 REFUSAL OF TREATMENT BY PATIENT 8 0.0012
425 CHRONIC KIDNEY DISEASE 93 0.0012
426 ABNORMAL FAECES 10 0.0012
427 ANXIETY 346 0.0012
428 CONFUSIONAL STATE 195 0.0012
429 DRUG ADMINISTRATION ERROR 37 0.0012
430 CEREBRAL INFARCTION 29 0.0012
431 DRY MOUTH 96 0.0012
432 CRYING 43 0.0012
433 HYPERTHERMIA 9 0.0012
434 ISCHAEMIC STROKE 21 0.0012
435 BLISTER 66 0.0012
436 ABNORMAL LOSS OF WEIGHT 8 0.0012
437 FEMORAL NECK FRACTURE 6 0.0012
438 ANURIA 10 0.0012
439 LYMPHOEDEMA 8 0.0012
440 DIARRHOEA 746 0.0012
441 PERIORBITAL OEDEMA 6 0.0012
442 DRUG LEVEL INCREASED 19 0.0011
443 NEUTROPENIA 154 0.0011
444 BONE MARROW FAILURE 23 0.0011
445 PURPURA 10 0.0011
446 OLIGURIA 7 0.0011
447 RETINAL HAEMORRHAGE 8 0.0011
448 THERAPY NON-RESPONDER 50 0.0011
449 FOOT FRACTURE 21 0.0011
450 INCORRECT DRUG ADMINISTRATION DURATION 31 0.0011
451 PARANOIA 19 0.0011
452 BLOOD THYROID STIMULATING HORMONE DECREASED 5 0.0011
453 LIVER FUNCTION TEST ABNORMAL 32 0.0011
454 INCREASED APPETITE 21 0.0011
455 OESOPHAGITIS 12 0.0011
456 END STAGE RENAL DISEASE 20 0.0011
457 ESCHERICHIA INFECTION 9 0.0011
458 SUICIDAL IDEATION 100 0.0011
459 RASH PRURITIC 59 0.0011
460 DYSPNOEA EXERTIONAL 41 0.0011
461 COLITIS 41 0.0011
462 COAGULOPATHY 18 0.0011
463 NEUTROPHIL COUNT DECREASED 44 0.0011
464 BLOOD CREATINE PHOSPHOKINASE INCREASED 31 0.0011
465 NEPHROLITHIASIS 49 0.0011
466 FLANK PAIN 10 0.0011
467 OEDEMA PERIPHERAL 130 0.0011
468 VERTIGO 65 0.0011
469 SLEEP DISORDER 75 0.0011
470 HEPATOCELLULAR INJURY 15 0.0011
471 DYSPEPSIA 104 0.0011
472 NEUTROPHILIA 6 0.0011
473 SPUTUM DISCOLOURED 10 0.0011
474 GRANULOCYTOPENIA 6 0.0011
475 ACUTE MYOCARDIAL INFARCTION 31 0.0011
476 OEDEMA 57 0.0010
477 CARDIAC FAILURE ACUTE 7 0.0010
478 MYOCARDITIS 12 0.0010
479 NEOPLASM 12 0.0010
480 GASTRIC HAEMORRHAGE 12 0.0010
481 TREATMENT NONCOMPLIANCE 57 0.0010
482 BONE PAIN 61 0.0010
483 METASTASES TO LUNG 12 0.0010
484 PLEURAL EFFUSION 63 0.0010
485 DISORIENTATION 41 0.0010
486 EAR PAIN 20 0.0010
487 WEIGHT DECREASED 287 0.0010
488 FALL 342 0.0010
489 MEMORY IMPAIRMENT 141 0.0010
490 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 9 0.0010
491 DECREASED INTEREST 6 0.0010
492 HALLUCINATION, AUDITORY 16 0.0010
493 ABDOMINAL TENDERNESS 5 0.0010
494 CARDIAC PACEMAKER INSERTION 6 0.0010
495 HYPOMAGNESAEMIA 14 0.0010
496 ASPIRATION 11 0.0010
497 DERMATITIS 21 0.0010
498 GASTROENTERITIS VIRAL 18 0.0010
499 CARDIAC FAILURE 80 0.0010
500 LEUKOCYTOSIS 18 0.0010
501 DUODENAL ULCER 7 0.0010
502 INGUINAL HERNIA 6 0.0010
503 EATING DISORDER 21 0.0010
504 DRY THROAT 10 0.0010
505 MALNUTRITION 11 0.0010
506 RETINAL DETACHMENT 9 0.0010
507 EAR DISCOMFORT 10 0.0010
508 FEELING COLD 27 0.0010
509 SPINAL COMPRESSION FRACTURE 8 0.0010
510 HAEMATOMA 25 0.0010
511 VISUAL ACUITY REDUCED 32 0.0010
512 CHOLECYSTECTOMY 11 0.0010
513 MOUTH HAEMORRHAGE 7 0.0010
514 AGITATION 70 0.0010
515 AMNESIA 62 0.0010
516 CHEST PAIN 176 0.0009
517 EPISTAXIS 71 0.0009
518 PSYCHIATRIC SYMPTOM 7 0.0009
519 INTERNATIONAL NORMALISED RATIO INCREASED 27 0.0009
520 PANCREATITIS 50 0.0009
521 METABOLIC ACIDOSIS 30 0.0009
522 FEEDING DISORDER 19 0.0009
523 ATRIAL FIBRILLATION 91 0.0009
524 HUNGER 13 0.0009
525 ATELECTASIS 9 0.0009
526 BREAST TENDERNESS 7 0.0009
527 ABDOMINAL DISTENSION 97 0.0009
528 DECREASED ACTIVITY 10 0.0009
529 HEPATIC ENZYME INCREASED 63 0.0009
530 FAECES DISCOLOURED 20 0.0009
531 PLATELET COUNT INCREASED 12 0.0009
532 LYMPHOPENIA 13 0.0009
533 HAEMODYNAMIC INSTABILITY 7 0.0009
534 RENAL TUBULAR NECROSIS 9 0.0009
535 HEPATOMEGALY 9 0.0009
536 HYPOGAMMAGLOBULINAEMIA 6 0.0009
537 THINKING ABNORMAL 17 0.0009
538 COLD SWEAT 16 0.0009
539 RECTAL HAEMORRHAGE 39 0.0009
540 GENERAL PHYSICAL HEALTH DETERIORATION 105 0.0009
541 TUBULOINTERSTITIAL NEPHRITIS 17 0.0009
542 LOSS OF CONSCIOUSNESS 116 0.0009
543 GASTRIC DISORDER 31 0.0009
544 GAMMA-GLUTAMYLTRANSFERASE INCREASED 20 0.0009
545 RENAL DISORDER 42 0.0009
546 NERVOUSNESS 47 0.0009
547 DYSURIA 33 0.0009
548 FACIAL PAIN 8 0.0009
549 PROTEINURIA 17 0.0009
550 ORAL PAIN 20 0.0009
551 GASTROINTESTINAL INFECTION 8 0.0009
552 GOUT 16 0.0009
553 ACUTE PULMONARY OEDEMA 5 0.0009
554 IMPAIRED WORK ABILITY 19 0.0009
555 PALPITATIONS 104 0.0009
556 ALOPECIA 173 0.0009
557 CIRCULATORY COLLAPSE 15 0.0009
558 INFARCTION 6 0.0009
559 PNEUMONIA BACTERIAL 8 0.0009
560 ORAL HERPES 17 0.0009
561 CLOSTRIDIUM DIFFICILE INFECTION 19 0.0009
562 DEHYDRATION 116 0.0009
563 ABNORMAL DREAMS 24 0.0009
564 PERITONITIS 18 0.0009
565 PNEUMONIA 281 0.0009
566 ENCEPHALITIS 6 0.0009
567 URINARY TRACT INFECTION 147 0.0009
568 DYSGEUSIA 64 0.0009
569 PERSONALITY CHANGE 8 0.0009
570 LOCAL SWELLING 15 0.0009
571 TRANSIENT ISCHAEMIC ATTACK 29 0.0009
572 MIDDLE INSOMNIA 16 0.0009
573 LIVER INJURY 21 0.0009
574 LETHARGY 49 0.0009
575 BLOOD SODIUM DECREASED 16 0.0008
576 GASTROINTESTINAL DISORDER 76 0.0008
577 DIABETES MELLITUS INADEQUATE CONTROL 15 0.0008
578 OVERDOSE 182 0.0008
579 OROPHARYNGEAL PAIN 78 0.0008
580 FEELING JITTERY 16 0.0008
581 CHOLECYSTITIS 10 0.0008
582 INCORRECT PRODUCT STORAGE 11 0.0008
583 GASTRITIS 22 0.0008
584 ORAL CANDIDIASIS 11 0.0008
585 RESPIRATORY DISTRESS 23 0.0008
586 DEPRESSED MOOD 44 0.0008
587 TOOTHACHE 15 0.0008
588 BIPOLAR DISORDER 9 0.0008
589 SHOCK 19 0.0008
590 DIZZINESS POSTURAL 8 0.0008
591 EYE HAEMORRHAGE 11 0.0008
592 RASH PUSTULAR 6 0.0008
593 SCHIZOPHRENIA 10 0.0008
594 RESPIRATORY TRACT CONGESTION 13 0.0008
595 DRY SKIN 109 0.0008
596 INJECTION SITE RASH 25 0.0008
597 BLOOD GLUCOSE ABNORMAL 15 0.0008
598 NIGHT SWEATS 26 0.0008
599 HYPERHIDROSIS 103 0.0008
600 VENTRICULAR TACHYCARDIA 13 0.0008
601 TOOTH ABSCESS 8 0.0008
602 MYOSITIS 7 0.0008
603 RENAL FAILURE ACUTE 33 0.0008
604 MUSCULOSKELETAL CHEST PAIN 12 0.0008
605 CARDIAC ARREST 64 0.0008
606 HIATUS HERNIA 10 0.0008
607 COGNITIVE DISORDER 36 0.0008
608 LIP DRY 7 0.0008
609 GASTROOESOPHAGEAL REFLUX DISEASE 62 0.0008
610 POLLAKIURIA 32 0.0008
611 HYPOKALAEMIA 35 0.0008
612 ACTIVITIES OF DAILY LIVING IMPAIRED 15 0.0008
613 FURUNCLE 6 0.0008
614 INFLUENZA 84 0.0008
615 INFECTION 109 0.0008
616 VIRAL INFECTION 25 0.0008
617 PREGNANCY 15 0.0007
618 DIABETES MELLITUS 57 0.0007
619 BACK PAIN 173 0.0007
620 RHABDOMYOLYSIS 31 0.0007
621 PANIC ATTACK 27 0.0007
622 ACUTE RESPIRATORY DISTRESS SYNDROME 13 0.0007
623 ABDOMINAL DISCOMFORT 123 0.0007
624 BLOOD POTASSIUM DECREASED 22 0.0007
625 METASTASES TO BONE 12 0.0007
626 BLOOD TESTOSTERONE DECREASED 5 0.0007
627 HERPES ZOSTER 42 0.0007
628 WOUND INFECTION 8 0.0007
629 HYPERCALCAEMIA 9 0.0007
630 DEAFNESS 19 0.0007
631 LOWER RESPIRATORY TRACT INFECTION 33 0.0007
632 SPEECH DISORDER 38 0.0007
633 BLOOD ALKALINE PHOSPHATASE INCREASED 18 0.0007
634 ILEUS 9 0.0007
635 CYTOMEGALOVIRUS INFECTION 12 0.0007
636 HEMIPLEGIA 6 0.0007
637 DRUG DISPENSING ERROR 11 0.0007
638 DYSARTHRIA 27 0.0007
639 ATRIAL SEPTAL DEFECT 6 0.0007
640 VITREOUS FLOATERS 7 0.0007
641 LABORATORY TEST ABNORMAL 21 0.0007
642 CONSTIPATION 155 0.0007
643 MUSCLE ATROPHY 9 0.0007
644 DELUSION 11 0.0007
645 DIALYSIS 10 0.0007
646 RESPIRATORY FAILURE 51 0.0007
647 CARDIAC MURMUR 6 0.0007
648 HYPOTHERMIA 7 0.0007
649 ULCER 11 0.0007
650 HYPERTHYROIDISM 10 0.0007
651 LIP SWELLING 23 0.0007
652 NODULE 9 0.0007
653 ELECTROLYTE IMBALANCE 8 0.0007
654 EYELID OEDEMA 8 0.0007
655 EPILEPSY 21 0.0007
656 VISUAL IMPAIRMENT 85 0.0007
657 BEDRIDDEN 9 0.0007
658 NEUROPATHY PERIPHERAL 65 0.0007
659 INITIAL INSOMNIA 7 0.0007
660 IMMUNOSUPPRESSION 6 0.0007
661 AGGRESSION 34 0.0007
662 PULMONARY FIBROSIS 13 0.0007
663 HYPONATRAEMIA 38 0.0007
664 ATAXIA 8 0.0007
665 EYE DISCHARGE 7 0.0007
666 HEPATOTOXICITY 15 0.0007
667 MIGRAINE 64 0.0007
668 FEELING HOT 41 0.0007
669 POLYNEUROPATHY 8 0.0007
670 PRODUCT USE ISSUE 125 0.0007
671 MOUTH ULCERATION 14 0.0007
672 CHEST DISCOMFORT 68 0.0007
673 TREMOR 110 0.0007
674 THERAPY CESSATION 34 0.0007
675 PNEUMONITIS 18 0.0007
676 OPTIC NEURITIS 6 0.0007
677 RESTLESS LEGS SYNDROME 12 0.0007
678 STOMATITIS 40 0.0007
679 NEOPLASM MALIGNANT 44 0.0007
680 NEURALGIA 16 0.0007
681 SEIZURE 76 0.0007
682 FACE OEDEMA 11 0.0007
683 IRON DEFICIENCY ANAEMIA 6 0.0006
684 PRODUCT QUALITY ISSUE 88 0.0006
685 CONJUNCTIVITIS 12 0.0006
686 FEELING ABNORMAL 154 0.0006
687 NEPHROPATHY 6 0.0006
688 DIARRHOEA HAEMORRHAGIC 6 0.0006
689 BURNING SENSATION 45 0.0006
690 SECRETION DISCHARGE 8 0.0006
691 MUSCLE SPASMS 117 0.0006
692 ABORTION INDUCED 6 0.0006
693 FLATULENCE 36 0.0006
694 ORTHOSTATIC HYPOTENSION 11 0.0006
695 VENTRICULAR FIBRILLATION 7 0.0006
696 HYPERSOMNIA 18 0.0006
697 WHITE BLOOD CELL COUNT INCREASED 24 0.0006
698 BALANCE DISORDER 54 0.0006
699 DRUG PRESCRIBING ERROR 12 0.0006
700 PARAESTHESIA ORAL 9 0.0006
701 ACUTE RESPIRATORY FAILURE 12 0.0006
702 PERIPHERAL SWELLING 96 0.0006
703 THROMBOSIS 50 0.0006
704 HYPOGLYCAEMIA 30 0.0006
705 IMPAIRED DRIVING ABILITY 7 0.0006
706 CELLULITIS 31 0.0006
707 HALLUCINATION 46 0.0006
708 DISEASE RECURRENCE 29 0.0006
709 SKIN DISCOLOURATION 28 0.0006
710 CARDIOMYOPATHY 9 0.0006
711 SWOLLEN TONGUE 19 0.0006
712 BRONCHITIS 45 0.0006
713 ADVERSE EVENT 56 0.0006
714 PRODUCTIVE COUGH 29 0.0006
715 PAIN 373 0.0006
716 PERICARDIAL EFFUSION 14 0.0006
717 DELIRIUM 21 0.0006
718 PSYCHOMOTOR HYPERACTIVITY 10 0.0006
719 MYOCARDIAL INFARCTION 105 0.0006
720 HAIR TEXTURE ABNORMAL 8 0.0006
721 PERICARDITIS 10 0.0006
722 EMPHYSEMA 6 0.0006
723 LYMPHADENOPATHY 21 0.0006
724 HEMIPARESIS 10 0.0006
725 SLUGGISHNESS 6 0.0006
726 HYPOPHAGIA 15 0.0006
727 ACCIDENT 7 0.0006
728 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 6 0.0006
729 THYROID DISORDER 9 0.0006
730 BLOOD URINE PRESENT 11 0.0006
731 BLOOD MAGNESIUM DECREASED 5 0.0006
732 CYTOPENIA 7 0.0006
733 FLUID RETENTION 29 0.0006
734 SCRATCH 6 0.0006
735 SMALL INTESTINAL OBSTRUCTION 7 0.0006
736 JOINT DISLOCATION 6 0.0006
737 RENAL PAIN 6 0.0006
738 SCIATICA 9 0.0006
739 EYE SWELLING 21 0.0006
740 DRUG ERUPTION 10 0.0006
741 DYSPHONIA 33 0.0006
742 APHASIA 17 0.0006
743 RETCHING 12 0.0006
744 PNEUMONIA ASPIRATION 14 0.0006
745 SUBDURAL HAEMATOMA 8 0.0006
746 ELECTROCARDIOGRAM QT PROLONGED 20 0.0006
747 BLOOD GLUCOSE FLUCTUATION 6 0.0005
748 STAPHYLOCOCCAL INFECTION 18 0.0005
749 CONTUSION 52 0.0005
750 SKIN HAEMORRHAGE 8 0.0005
751 BODY TEMPERATURE INCREASED 11 0.0005
752 HYPOTENSION 108 0.0005
753 HAEMOPTYSIS 15 0.0005
754 ECZEMA 28 0.0005
755 HAEMORRHAGE INTRACRANIAL 8 0.0005
756 THERAPEUTIC RESPONSE UNEXPECTED 24 0.0005
757 RESPIRATORY DISORDER 16 0.0005
758 MUSCULOSKELETAL PAIN 28 0.0005
759 FISTULA 6 0.0005
760 EYE INFECTION 6 0.0005
761 HEART RATE IRREGULAR 12 0.0005
762 DEPRESSED LEVEL OF CONSCIOUSNESS 21 0.0005
763 ABNORMAL BEHAVIOUR 21 0.0005
764 FRACTURE 10 0.0005
765 ADVERSE REACTION 7 0.0005
766 ABASIA 13 0.0005
767 DERMATITIS CONTACT 6 0.0005
768 HAEMORRHAGE 55 0.0005
769 EAR INFECTION 14 0.0005
770 RHINORRHOEA 34 0.0005
771 INTERNAL HAEMORRHAGE 6 0.0005
772 HYPERTENSION 111 0.0005
773 MEDICATION ERROR 29 0.0005
774 NECK PAIN 29 0.0005
775 FREQUENT BOWEL MOVEMENTS 14 0.0005
776 SINUS CONGESTION 7 0.0005
777 INJECTION SITE ERYTHEMA 64 0.0005
778 ACUTE MYELOID LEUKAEMIA 8 0.0005
779 CONDITION AGGRAVATED 156 0.0005
780 CARDIOVASCULAR DISORDER 13 0.0005
781 KIDNEY INFECTION 10 0.0005
782 LYMPHOCYTE COUNT DECREASED 9 0.0005
783 SINUS DISORDER 10 0.0005
784 BLOOD PRESSURE ABNORMAL 10 0.0005
785 RESPIRATORY TRACT INFECTION 13 0.0005
786 SKIN REACTION 7 0.0005
787 RASH MACULO-PAPULAR 11 0.0005
788 DEEP VEIN THROMBOSIS 32 0.0005
789 COLITIS ULCERATIVE 22 0.0005
790 LUNG DISORDER 24 0.0005
791 HYPOAESTHESIA 73 0.0005
792 ERYTHEMA 100 0.0005
793 HEPATIC STEATOSIS 9 0.0005
794 TOOTH EXTRACTION 6 0.0005
795 ROAD TRAFFIC ACCIDENT 20 0.0005
796 DEATH 411 0.0005
797 DERMATITIS ALLERGIC 6 0.0005
798 UPPER RESPIRATORY TRACT INFECTION 22 0.0005
799 TYPE 2 DIABETES MELLITUS 16 0.0005
800 INTERSTITIAL LUNG DISEASE 23 0.0005
801 ABDOMINAL PAIN LOWER 12 0.0005
802 HEAD INJURY 15 0.0005
803 CARDIAC FAILURE CONGESTIVE 38 0.0005
804 DRUG EFFECT INCOMPLETE 17 0.0005
805 ERECTILE DYSFUNCTION 12 0.0005
806 MUSCULAR WEAKNESS 53 0.0005
807 LIVER FUNCTION TEST INCREASED 10 0.0005
808 LACRIMATION INCREASED 14 0.0005
809 NIGHTMARE 16 0.0005
810 LUNG NEOPLASM MALIGNANT 19 0.0005
811 RASH MACULAR 16 0.0005
812 ANHEDONIA 12 0.0005
813 DRUG INTOLERANCE 44 0.0005
814 BLOOD TRIGLYCERIDES INCREASED 8 0.0005
815 FIBROMYALGIA 11 0.0005
816 BLOOD PRESSURE DECREASED 30 0.0005
817 NERVOUS SYSTEM DISORDER 14 0.0004
818 QUALITY OF LIFE DECREASED 6 0.0004
819 PRODUCT PHYSICAL ISSUE 9 0.0004
820 BLOOD LACTATE DEHYDROGENASE INCREASED 7 0.0004
821 PALLOR 12 0.0004
822 PREMATURE DELIVERY 7 0.0004
823 RASH ERYTHEMATOUS 21 0.0004
824 UNDERDOSE 32 0.0004
825 PAIN IN EXTREMITY 129 0.0004
826 OSTEOPOROSIS 18 0.0004
827 RIB FRACTURE 9 0.0004
828 SKIN LESION 12 0.0004
829 PERIPHERAL COLDNESS 6 0.0004
830 HEART RATE INCREASED 43 0.0004
831 MUSCLE TWITCHING 10 0.0004
832 BLOOD POTASSIUM INCREASED 7 0.0004
833 AGRANULOCYTOSIS 8 0.0004
834 APHONIA 6 0.0004
835 CORONARY ARTERY DISEASE 13 0.0004
836 WEIGHT INCREASED 96 0.0004
837 ABORTION SPONTANEOUS 17 0.0004
838 SEASONAL ALLERGY 6 0.0004
839 PAIN IN JAW 12 0.0004
840 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 30 0.0004
841 PULMONARY EMBOLISM 40 0.0004
842 DRY EYE 21 0.0004
843 HYPOACUSIS 18 0.0004
844 BLOOD UREA INCREASED 7 0.0004
845 MYELODYSPLASTIC SYNDROME 6 0.0004
846 PRODUCT DOSE OMISSION 27 0.0004
847 ERUCTATION 8 0.0004
848 PARAESTHESIA 65 0.0004
849 CHOKING 8 0.0004
850 SURGERY 24 0.0004
851 MENORRHAGIA 8 0.0004
852 SWELLING 38 0.0004
853 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 21 0.0004
854 GLOSSODYNIA 9 0.0004
855 INTESTINAL OBSTRUCTION 15 0.0004
856 INTENTIONAL SELF-INJURY 8 0.0004
857 ECONOMIC PROBLEM 6 0.0004
858 SUICIDE ATTEMPT 24 0.0004
859 GALLBLADDER DISORDER 7 0.0004
860 SKIN EXFOLIATION 33 0.0004
861 DYSPHAGIA 37 0.0004
862 URINARY RETENTION 13 0.0004
863 INFLAMMATION 20 0.0004
864 FEMUR FRACTURE 12 0.0004
865 TOOTH LOSS 8 0.0004
866 PULMONARY HYPERTENSION 8 0.0004
867 MATERNAL EXPOSURE DURING PREGNANCY 34 0.0004
868 PULMONARY OEDEMA 17 0.0004
869 ANKYLOSING SPONDYLITIS 5 0.0004
870 OCULAR HYPERAEMIA 18 0.0004
871 HALLUCINATION, VISUAL 8 0.0004
872 ABSCESS 6 0.0004
873 SENSORY DISTURBANCE 6 0.0004
874 LOCALISED INFECTION 9 0.0004
875 CEREBROVASCULAR ACCIDENT 63 0.0004
876 EXTRA DOSE ADMINISTERED 15 0.0004
877 SWELLING FACE 24 0.0004
878 MUSCULOSKELETAL STIFFNESS 32 0.0004
879 EYE DISORDER 12 0.0004
880 HAEMATOCHEZIA 20 0.0004
881 AGEUSIA 9 0.0004
882 STEVENS-JOHNSON SYNDROME 8 0.0004
883 HAEMORRHOIDS 7 0.0004
884 SKIN FISSURES 7 0.0004
885 SNEEZING 8 0.0004
886 GASTRIC CANCER 9 0.0004
887 INTENTIONAL PRODUCT USE ISSUE 31 0.0004
888 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 9 0.0003
889 INJECTION SITE REACTION 24 0.0003
890 UNRESPONSIVE TO STIMULI 9 0.0003
891 CYSTITIS 11 0.0003
892 HYPOTHYROIDISM 11 0.0003
893 INJURY ASSOCIATED WITH DEVICE 7 0.0003
894 HIP FRACTURE 11 0.0003
895 METASTASES TO LIVER 6 0.0003
896 HYPOXIA 12 0.0003
897 GAIT DISTURBANCE 65 0.0003
898 ANGIOEDEMA 15 0.0003
899 URINARY INCONTINENCE 10 0.0003
900 WHEEZING 20 0.0003
901 RENAL INJURY 10 0.0003
902 CONVULSION 19 0.0003
903 SINUSITIS 34 0.0003
904 CARDIAC DISORDER 31 0.0003
905 WRONG TECHNIQUE IN DRUG USAGE PROCESS 12 0.0003
906 DISEASE PROGRESSION 39 0.0003
907 DISCOMFORT 20 0.0003
908 LIMB DISCOMFORT 10 0.0003
909 ACCIDENTAL EXPOSURE TO PRODUCT 33 0.0003
910 NASOPHARYNGITIS 59 0.0003
911 INTENTIONAL DOSE OMISSION 9 0.0003
912 MUSCULOSKELETAL DISORDER 6 0.0003
913 BLOOD GLUCOSE INCREASED 59 0.0003
914 INJECTION SITE HAEMORRHAGE 25 0.0003
915 HERNIA 6 0.0003
916 HYPERSENSITIVITY 57 0.0003
917 NASAL CONGESTION 18 0.0003
918 HOT FLUSH 23 0.0003
919 INJECTION SITE BRUISING 24 0.0003
920 ADVERSE DRUG REACTION 27 0.0003
921 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 7 0.0003
922 FUNGAL INFECTION 10 0.0003
923 INJECTION SITE PRURITUS 20 0.0003
924 CONTRAINDICATED PRODUCT ADMINISTERED 9 0.0003
925 PAIN OF SKIN 8 0.0003
926 URTICARIA 49 0.0003
927 THROAT IRRITATION 13 0.0003
928 PLASMA CELL MYELOMA 11 0.0003
929 MOVEMENT DISORDER 9 0.0003
930 TOXICITY TO VARIOUS AGENTS 47 0.0003
931 COMPLETED SUICIDE 23 0.0003
932 OSTEONECROSIS 9 0.0003
933 EXPOSURE DURING PREGNANCY 17 0.0003
934 BLOOD GLUCOSE DECREASED 13 0.0003
935 TOOTH DISORDER 6 0.0003
936 EYE PRURITUS 9 0.0003
937 EYE IRRITATION 15 0.0003
938 FEAR 7 0.0003
939 THROAT TIGHTNESS 7 0.0003
940 DIVERTICULITIS 7 0.0003
941 DRUG WITHDRAWAL SYNDROME 22 0.0003
942 DEMENTIA 7 0.0003
943 INJECTION SITE URTICARIA 6 0.0002
944 FEBRILE NEUTROPENIA 16 0.0002
945 DYSSTASIA 7 0.0002
946 PSORIASIS 31 0.0002
947 SKIN BURNING SENSATION 16 0.0002
948 C-REACTIVE PROTEIN INCREASED 8 0.0002
949 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 12 0.0002
950 SKIN IRRITATION 10 0.0002
951 RESPIRATORY ARREST 6 0.0002
952 INTENTIONAL PRODUCT MISUSE 19 0.0002
953 DRUG ABUSE 18 0.0002
954 ARTHROPATHY 12 0.0002
955 NO ADVERSE EVENT 39 0.0002
956 WOUND 6 0.0002
957 FOETAL EXPOSURE DURING PREGNANCY 17 0.0002
958 MOBILITY DECREASED 15 0.0002
959 BLOOD PRESSURE FLUCTUATION 5 0.0002
960 HOSPITALISATION 32 0.0002
961 ANAPHYLACTIC REACTION 11 0.0002
962 THERAPEUTIC RESPONSE DECREASED 12 0.0002
963 GYNAECOMASTIA 6 0.0002
964 RHEUMATOID ARTHRITIS 22 0.0002
965 ARTHRITIS 15 0.0002
966 JOINT SWELLING 23 0.0002
967 WITHDRAWAL SYNDROME 8 0.0002
968 PRODUCT USE IN UNAPPROVED INDICATION 46 0.0002
969 IMPAIRED HEALING 6 0.0002
970 EMOTIONAL DISTRESS 21 0.0002
971 DYSKINESIA 7 0.0002
972 CATARACT 10 0.0002
973 FLUSHING 17 0.0002
974 MYELOSUPPRESSION 6 0.0002
975 INTENTIONAL OVERDOSE 10 0.0002
976 ASTHMA 17 0.0002
977 BREAST CANCER 14 0.0002
978 VAGINAL HAEMORRHAGE 6 0.0001
979 INCORRECT DOSE ADMINISTERED 31 0.0001
980 INJECTION SITE SWELLING 10 0.0001
981 DEVICE MALFUNCTION 9 0.0001
982 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 24 0.0001
983 BLOOD CHOLESTEROL INCREASED 5 0.0001
984 MALIGNANT NEOPLASM PROGRESSION 10 0.0001
985 ACNE 7 0.0001
986 INJURY 6 0.0001
987 INJECTION SITE PAIN 26 0.0001
988 PROSTATE CANCER 6 0.0001
989 DRUG DEPENDENCE 11 0.0001
990 PRODUCT DOSE OMISSION ISSUE 7 0.0000